HealthStream (NASDAQ:HSTM) Stock Price Expected to Rise, Canaccord Genuity Group Analyst Says

HealthStream (NASDAQ:HSTM) had its target price boosted by equities researchers at Canaccord Genuity Group from $24.00 to $27.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm presently has a “hold” rating on the technology company’s stock. Canaccord Genuity Group’s target price indicates a potential downside of 4.69% from the company’s current price.

Several other research analysts have also commented on HSTM. Wall Street Zen upgraded shares of HealthStream from a “hold” rating to a “buy” rating in a report on Saturday, May 9th. Weiss Ratings upgraded shares of HealthStream from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, June 23rd. Three analysts have rated the stock with a Hold rating, Based on data from MarketBeat, HealthStream presently has an average rating of “Hold” and an average price target of $27.00.

HealthStream Trading Down 0.5%

HSTM stock opened at $28.33 on Tuesday. The stock has a 50-day moving average price of $26.01 and a two-hundred day moving average price of $22.99. HealthStream has a 12-month low of $19.50 and a 12-month high of $30.00. The company has a market cap of $827.80 million, a PE ratio of 42.28, a price-to-earnings-growth ratio of 3.23 and a beta of 0.45.

HealthStream (NASDAQ:HSTM) last released its quarterly earnings data on Monday, May 4th. The technology company reported $0.20 EPS for the quarter, topping analysts’ consensus estimates of $0.16 by $0.04. The company had revenue of $81.20 million for the quarter, compared to the consensus estimate of $79.68 million. HealthStream had a return on equity of 6.47% and a net margin of 6.39%. Equities analysts forecast that HealthStream will post 0.74 EPS for the current fiscal year.

Insider Transactions at HealthStream

In other news, EVP Kevin P. O’hara sold 3,000 shares of the stock in a transaction dated Wednesday, May 20th. The stock was sold at an average price of $24.08, for a total value of $72,240.00. Following the completion of the sale, the executive vice president owned 20,982 shares in the company, valued at approximately $505,246.56. This trade represents a 12.51% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Linda Rebrovick sold 6,000 shares of the firm’s stock in a transaction dated Monday, July 6th. The shares were sold at an average price of $29.00, for a total value of $174,000.00. Following the sale, the director owned 51,329 shares in the company, valued at approximately $1,488,541. The trade was a 10.47% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 11,000 shares of company stock valued at $296,240. Insiders own 20.40% of the company’s stock.

Institutional Trading of HealthStream

A number of hedge funds have recently made changes to their positions in the company. MassMutual Private Wealth & Trust FSB lifted its stake in HealthStream by 76.4% during the second quarter. MassMutual Private Wealth & Trust FSB now owns 1,025 shares of the technology company’s stock valued at $28,000 after buying an additional 444 shares in the last quarter. The Manufacturers Life Insurance Company increased its position in shares of HealthStream by 6.7% in the second quarter. The Manufacturers Life Insurance Company now owns 9,354 shares of the technology company’s stock worth $259,000 after acquiring an additional 586 shares in the last quarter. Danske Bank A S increased its position in shares of HealthStream by 175.0% in the fourth quarter. Danske Bank A S now owns 1,100 shares of the technology company’s stock worth $25,000 after acquiring an additional 700 shares in the last quarter. Snowden Capital Advisors LLC raised its holdings in shares of HealthStream by 8.7% during the second quarter. Snowden Capital Advisors LLC now owns 10,196 shares of the technology company’s stock valued at $282,000 after acquiring an additional 816 shares during the period. Finally, Jane Street Group LLC raised its holdings in shares of HealthStream by 1.9% during the second quarter. Jane Street Group LLC now owns 48,533 shares of the technology company’s stock valued at $1,343,000 after acquiring an additional 922 shares during the period. Hedge funds and other institutional investors own 69.58% of the company’s stock.

HealthStream Company Profile

HealthStream, Inc is a Nashville, Tennessee–based provider of workforce development and learning management solutions for healthcare organizations. Since its founding in 1990, the company has focused on helping hospitals, clinics and other care providers streamline staff training, ensure regulatory compliance and monitor employee performance. HealthStream’s platform integrates online courses, skill competency assessments and credential management tools to support workforce readiness across the healthcare continuum.

The company’s core offerings include a learning management system (LMS) designed specifically for clinical and nonclinical personnel, a competency management suite that tracks skill acquisition and validation, and a content library featuring evidence-based clinical and compliance training modules.